HealthCare Global Enterprises Limited
Symboli: HCG.BO
BSE
360.1
INRMarkkinahinta tänään
142.5224
P/E-suhde
-2.9066
PEG-suhde
50.16B
MRK Cap
- 0.00%
DIV Tuotto
HealthCare Global Enterprises Limited (HCG-BO) Tilinpäätöstiedotteet
Tase
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 0 | 1746.2 | 2041.5 | 1657.3 | |||||||||
balance-sheet.row.short-term-investments | 0 | 292.3 | 66.4 | 1357.3 | |||||||||
balance-sheet.row.net-receivables | 0 | 3095.5 | 2428.1 | 2148 | |||||||||
balance-sheet.row.inventory | 0 | 382.9 | 299.7 | 211.1 | |||||||||
balance-sheet.row.other-current-assets | 0 | 339.2 | 216.8 | 224.7 | |||||||||
balance-sheet.row.total-current-assets | 0 | 5803.4 | 5023.4 | 4349.6 | |||||||||
balance-sheet.row.property-plant-equipment-net | 0 | 13712.7 | 13577.9 | 12945.6 | |||||||||
balance-sheet.row.goodwill | 0 | 1812.3 | 1812.7 | 963.4 | |||||||||
balance-sheet.row.intangible-assets | 0 | 186.7 | 298 | 214.9 | |||||||||
balance-sheet.row.goodwill-and-intangible-assets | 0 | 1999.1 | 2110.7 | 1178.3 | |||||||||
balance-sheet.row.long-term-investments | 0 | 248 | 257.3 | 875.9 | |||||||||
balance-sheet.row.tax-assets | 0 | 52.7 | 59.6 | 343.1 | |||||||||
balance-sheet.row.other-non-current-assets | 0 | 1344.3 | 1166.4 | 663.6 | |||||||||
balance-sheet.row.total-non-current-assets | 0 | 17356.8 | 17171.9 | 16006.5 | |||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.total-assets | 0 | 23160.2 | 22195.2 | 20356.1 | |||||||||
balance-sheet.row.account-payables | 0 | 2484.5 | 1939.4 | 1455.2 | |||||||||
balance-sheet.row.short-term-debt | 0 | 864 | 859 | 1624.2 | |||||||||
balance-sheet.row.tax-payables | 0 | 24.7 | 5.3 | 3.5 | |||||||||
balance-sheet.row.long-term-debt-total | 0 | 8148 | 8287.8 | 8154.9 | |||||||||
Deferred Revenue Non Current | 0 | 359.3 | 255 | 279.8 | |||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 0 | - | - | - | |||||||||
balance-sheet.row.other-current-liab | 0 | 2113.2 | 1604.6 | 1351.8 | |||||||||
balance-sheet.row.total-non-current-liabilities | 0 | 8762.8 | 8660.6 | 8563.7 | |||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.capital-lease-obligations | 0 | 5018.6 | 5070.4 | 5058.2 | |||||||||
balance-sheet.row.total-liab | 0 | 14466 | 13358.1 | 13216.1 | |||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||
balance-sheet.row.common-stock | 0 | 1391.2 | 1390.1 | 1253.6 | |||||||||
balance-sheet.row.retained-earnings | 0 | -4522.4 | -4365.5 | -4751 | |||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 0 | 13040 | 13019.1 | 11228.1 | |||||||||
balance-sheet.row.other-total-stockholders-equity | 0 | -1303.5 | -1340.9 | -758.9 | |||||||||
balance-sheet.row.total-stockholders-equity | 0 | 8605.2 | 8702.9 | 6971.8 | |||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 0 | 23160.2 | 22195.2 | 20356.1 | |||||||||
balance-sheet.row.minority-interest | 0 | 88.9 | 134.3 | 168.2 | |||||||||
balance-sheet.row.total-equity | 0 | 8694.2 | 8837.1 | 7140 | |||||||||
balance-sheet.row.total-liabilities-and-total-equity | 0 | - | - | - | |||||||||
Total Investments | 0 | 226.6 | 249.5 | 388.5 | |||||||||
balance-sheet.row.total-debt | 0 | 9012 | 9146.8 | 9779 | |||||||||
balance-sheet.row.net-debt | 0 | 7265.8 | 7171.7 | 9479 |
Kassavirtalaskelma
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 0 | 448.8 | 877.7 | -2286.6 | |||||||||
cash-flows.row.depreciation-and-amortization | 0 | 1634.7 | 1582.8 | 1592.2 | |||||||||
cash-flows.row.deferred-income-tax | 0 | -33.5 | -65.9 | 486.5 | |||||||||
cash-flows.row.stock-based-compensation | 0 | 65.1 | 31 | 19.1 | |||||||||
cash-flows.row.change-in-working-capital | 0 | -458.7 | -105.2 | -507.1 | |||||||||
cash-flows.row.account-receivables | 0 | -785.5 | -404.4 | -78.5 | |||||||||
cash-flows.row.inventory | 0 | -83.1 | -60.8 | 21.5 | |||||||||
cash-flows.row.account-payables | 0 | 563.5 | 442.9 | -528.9 | |||||||||
cash-flows.row.other-working-capital | 0 | -153.5 | -83 | 78.8 | |||||||||
cash-flows.row.other-non-cash-items | 0 | 859.4 | -119.3 | 1901.2 | |||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.investments-in-property-plant-an-equipment | 0 | -1332.4 | -712.3 | -354.2 | |||||||||
cash-flows.row.acquisitions-net | 0 | 55.6 | 379.9 | -52.5 | |||||||||
cash-flows.row.purchases-of-investments | 0 | -634.1 | -824 | -2883.6 | |||||||||
cash-flows.row.sales-maturities-of-investments | 0 | 501.9 | 2278 | 1515.8 | |||||||||
cash-flows.row.other-investing-activites | 0 | 78.6 | 124.3 | 63.5 | |||||||||
cash-flows.row.net-cash-used-for-investing-activites | 0 | -1330.3 | 1245.9 | -1711 | |||||||||
cash-flows.row.debt-repayment | 0 | -627.6 | -3455.6 | -2631.7 | |||||||||
cash-flows.row.common-stock-issued | 0 | 8.9 | 1321.6 | 5194.4 | |||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.dividends-paid | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.other-financing-activites | 0 | -782 | 585.1 | -1440.2 | |||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | 0 | -1400.7 | -1548.8 | 1122.4 | |||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | |||||||||
cash-flows.row.net-change-in-cash | 0 | -215.1 | 1898.3 | 616.6 | |||||||||
cash-flows.row.cash-at-end-of-period | 0 | 1711.8 | 1926.9 | 28.6 | |||||||||
cash-flows.row.cash-at-beginning-of-period | 0 | 1926.9 | 28.6 | -587.9 | |||||||||
cash-flows.row.operating-cash-flow | 0 | 2515.9 | 2201.2 | 1205.2 | |||||||||
cash-flows.row.capital-expenditure | 0 | -1332.4 | -712.3 | -354.2 | |||||||||
cash-flows.row.free-cash-flow | 0 | 1183.5 | 1488.9 | 851 |
Tuloslaskelmarivi
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 0 | 16760.5 | 13831.4 | 10040.1 | |||||||||
income-statement-row.row.cost-of-revenue | 0 | 7997.6 | 6820.7 | 4998.5 | |||||||||
income-statement-row.row.gross-profit | 0 | 8762.9 | 7010.6 | 5041.6 | |||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||
income-statement-row.row.research-development | 0 | - | - | - | |||||||||
income-statement-row.row.selling-general-administrative | 0 | - | - | - | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.other-expenses | 0 | 6.1 | 5 | 11.9 | |||||||||
income-statement-row.row.operating-expenses | 0 | 7109.6 | 6236.2 | 5367.4 | |||||||||
income-statement-row.row.cost-and-expenses | 0 | 15107.2 | 13056.9 | 10366 | |||||||||
income-statement-row.row.interest-income | 0 | 118.1 | 115.6 | 156.1 | |||||||||
income-statement-row.row.interest-expense | 0 | 914.7 | 838.9 | 1103 | |||||||||
income-statement-row.row.selling-and-marketing-expenses | 0 | - | - | - | |||||||||
income-statement-row.row.total-other-income-expensenet | 0 | -1299.4 | -6.4 | -2017.2 | |||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||
income-statement-row.row.other-operating-expenses | 0 | 6.1 | 5 | 11.9 | |||||||||
income-statement-row.row.total-operating-expenses | 0 | -1299.4 | -6.4 | -2017.2 | |||||||||
income-statement-row.row.interest-expense | 0 | 914.7 | 838.9 | 1103 | |||||||||
income-statement-row.row.depreciation-and-amortization | 0 | 1634.7 | 1582.8 | 1592.2 | |||||||||
income-statement-row.row.ebitda-caps | 0 | - | - | - | |||||||||
income-statement-row.row.operating-income | 0 | 1653.2 | 788.4 | -368.4 | |||||||||
income-statement-row.row.income-before-tax | 0 | 448.8 | 877.7 | -2286.6 | |||||||||
income-statement-row.row.income-tax-expense | 0 | 272.5 | 488.5 | -75.6 | |||||||||
income-statement-row.row.net-income | 0 | 293.5 | 537.3 | -1934.6 |
Usein kysytty kysymys
Mikä on HealthCare Global Enterprises Limited (HCG.BO) taseen loppusumma?
HealthCare Global Enterprises Limited (HCG.BO) kokonaisvarat ovat 23160170000.000.
Mikä on yrityksen vuotuinen liikevaihto?
Vuotuinen liikevaihto on N/A.
Mikä on yrityksen voittomarginaali?
Yrityksen voittomarginaali on 0.517.
Mikä on yrityksen vapaa kassavirta?
Vapaa kassavirta on 2.531.
Mikä on yrityksen nettovoittomarginaali?
Nettovoittomarginaali on 0.019.
Mikä on yrityksen kokonaistulot?
Kokonaisliikevaihto on 0.076.
Mikä on HealthCare Global Enterprises Limited (HCG.BO) nettovoitto (nettotulos)?
Nettovoitto (nettotulos) on 293490000.000.
Mikä on yrityksen kokonaisvelka?
Kokonaisvelka on 9011980000.000.
Mikä on yrityksen toimintakulujen määrä?
Toimintakulut ovat 7109640000.000.
Mikä on yrityksen kassan määrä?
Yrityksen kassavarat ovat 0.000.